Trials / Conditions / JAK2 Mutation
JAK2 Mutation
4 registered clinical trials studyying JAK2 Mutation — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis NCT07249840 | Brigham and Women's Hospital | Phase 1 |
| Unknown | Global Coagulation Assessment in Portal Vein Thrombosis and Budd-Chiari Syndrome NCT05123326 | Post Graduate Institute of Medical Education and Research, Chandigarh | — |
| Completed | Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patient NCT04243122 | Ottawa Hospital Research Institute | Phase 2 |
| Unknown | Anticoagulation in Gastroesophageal Varices and JAK2 Mutation NCT04527666 | Shanghai Zhongshan Hospital | — |